Hims & Hers Health, Inc.
HIMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $2 | $1 | $1 |
| Revenue | $1 | $1 | $1 | $0 |
| % Growth | 69.3% | 65.5% | 93.8% | – |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 79.5% | 82% | 77.6% | 75.2% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 5.3% | -2.3% | -11.6% | -40.8% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 8.5% | -2.7% | -12.5% | -39.6% |
| EPS Diluted | 0.53 | -0.11 | -0.32 | -0.58 |
| % Growth | 581.8% | 65.6% | 44.8% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |